Axogen, Inc. (AXGN) stock
AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30152% above fair value
$56.95+1.58 (+2.85%)
Close on Nov 18, 2026Market cap $3.40BP/E –Yield –
Axogen net income
Net income is the profit left for shareholders after every expense, interest and tax.
Axogen's net income for the twelve months ending Sep 30, 2026 was -$31.92M. For fiscal 2025 it was -$15.70M. The highest annual figure on record is -$5.42M in fiscal 2010.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$15.70M | – |
| FY2024 | Dec 31, 2024 | -$9.96M | – |
| FY2023 | Dec 31, 2023 | -$21.72M | – |
| FY2022 | Dec 31, 2022 | -$28.95M | – |
| FY2021 | Dec 31, 2021 | -$26.99M | – |
| FY2020 | Dec 31, 2020 | -$23.79M | – |
| FY2019 | Dec 31, 2019 | -$29.14M | – |
| FY2018 | Dec 31, 2018 | -$22.40M | – |
| FY2017 | Dec 31, 2017 | -$10.45M | – |
| FY2016 | Dec 31, 2016 | -$14.41M | – |
| FY2015 | Dec 31, 2015 | -$13.36M | – |
| FY2014 | Dec 31, 2014 | -$17.71M | – |
| FY2013 | Dec 31, 2013 | -$14.56M | – |
| FY2012 | Dec 31, 2012 | -$9.42M | – |
| FY2011 | Dec 31, 2011 | -$9.22M | – |
| FY2010 | Dec 31, 2010 | -$5.42M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.33M | +229.7% |
| Q2 FY2026 | Jun 30, 2026 | -$1.52M | -361.8% |
| Q1 FY2026 | Mar 31, 2026 | -$19.58M | – |
| Q4 FY2025 | Dec 31, 2025 | -$13.16M | -3023.6% |
| Q3 FY2025 | Sep 30, 2025 | $708.00K | – |
| Q2 FY2025 | Jun 30, 2025 | $579.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.83M | – |
| Q4 FY2024 | Dec 31, 2024 | $450.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.86M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.92M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.64M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.89M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.09M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.66M | – |
| Q1 FY2023 | Mar 31, 2023 | -$7.07M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.42M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.32M | – |
| Q2 FY2022 | Jun 30, 2022 | -$7.74M | – |
| Q1 FY2022 | Mar 31, 2022 | -$11.48M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.29M | – |
| Q3 FY2021 | Sep 30, 2021 | -$7.14M | – |
| Q2 FY2021 | Jun 30, 2021 | -$7.90M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.66M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.01M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.48M | – |
| Q2 FY2020 | Jun 30, 2020 | -$8.11M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.19M | – |
| Q4 FY2019 | Dec 31, 2019 | -$7.04M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.57M | – |
| Q2 FY2019 | Jun 30, 2019 | -$7.02M | – |
| Q1 FY2019 | Mar 31, 2019 | -$9.50M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.22M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.10M | – |
| Q2 FY2018 | Jun 30, 2018 | -$7.43M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.64M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.50M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.12M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.06M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.76M | – |
| Q4 FY2016 | Dec 31, 2016 | -$5.63M | – |
See a number that looks wrong?